Document Detail

Norwegian cancer patients and the health food market--what is used and why?
MedLine Citation:
PMID:  16541172     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: There is limited knowledge about patients' use of herbs and dietary supplements. In the current project we have studied this in Norwegian patients, also their sources of information, beliefs and attitudes. MATERIAL AND METHODS: A structured questionnaire was filled in anonymously by 149 patients (response rate 64%) with common cancer diagnoses. RESULTS AND INTERPRETATION: Of the patients, 56% used herbs and dietary supplements (average: 2.0 products per patient), while 36% used them for the cancer itself (average: 1.1 products each). Patients below 55 significant dominated the last-mentioned group. Among the patients, 53% believed that the products could strengthen their immune system, while 18% believed that they could contribute in their fight against cancer. However, as many as 62% answered "I don't know" to this question. As to what was true about the products, 86% found it difficult to judge, and 76% wanted information primarily from health personnel. One third had discussed the products with the doctor. Only 8% felt this to be very useful; hence communicating with cancer patients about herbs and dietary supplements can be a challenge, though at least it might help to discover side effects or interaction with the medicine given.
Rolf Johansen; Else-Lydia Toverud
Publication Detail:
Type:  English Abstract; Journal Article    
Journal Detail:
Title:  Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række     Volume:  126     ISSN:  0807-7096     ISO Abbreviation:  Tidsskr. Nor. Laegeforen.     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-03-16     Completed Date:  2006-03-29     Revised Date:  2008-07-16    
Medline Journal Info:
Nlm Unique ID:  0413423     Medline TA:  Tidsskr Nor Laegeforen     Country:  Norway    
Other Details:
Languages:  nor     Pagination:  773-5     Citation Subset:  IM    
Farmasøytisk seksjon, Farmasøytisk Institutt, Universitetet i Oslo, Postboks 1068 Blindern, 0316 Oslo.
Vernacular Title:
Norske kreftpasienter og helsekostmarkedet--hva brukes og hvorfor?
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / administration & dosage,  adverse effects
Dietary Supplements / adverse effects,  utilization*
Food-Drug Interactions
Health Food / adverse effects,  utilization*
Herb-Drug Interactions
Middle Aged
Neoplasms / diet therapy,  drug therapy,  therapy*
Patient Education as Topic
Physician-Patient Relations
Phytotherapy / adverse effects,  utilization*
Plants, Medicinal* / adverse effects
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  How many and who are receiving medication for diabetes mellitus?
Next Document:  Dronedarone: a new antiarrhythmic agent.